UPDATE: NGM Biopharmaceuticals (NGM) PT Raised to $44 at Citi, 'High Conviction Buy' After Non-Deal Roadshow
Tweet Send to a Friend
(Updated - December 21, 2020 7:49 AM EST)
(updating comment)Citi analyst Joel Beatty raised the price target on NGM ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Citi analyst Joel Beatty raised the price target on NGM ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
